Impact of co-mutations and transcriptional signatures in non-small cell lung cancer patients treated with adagrasib in the KRYSTAL-1 trial.
Negrao MV, Paula AG, Molkentine D, Hover L, Nilsson M, Vokes N, Engstrom L, Calinisan A, Briere DM, Waters L, Hallin J, Diao L, Altan M, Blumenschein GR, Skoulidis F, Wang J, Kopetz SE, Hong DS, Gibbons DL, Olson P, Christensen JG, Heymach JV.
Negrao MV, et al. Among authors: diao l.
Clin Cancer Res. 2025 Jan 13. doi: 10.1158/1078-0432.CCR-24-2310. Online ahead of print.
Clin Cancer Res. 2025.
PMID: 39804166